INPLASY202490012

Efficacy of Rituximab as Second-Line Therapy for Autoimmune Encephalitis: A systematic review and meta-analysis

Keywords: rituximab, autoimmune encephalitis, treatment effects, N-methyl-D-aspartate receptor, Meta-analysis.

Review Status: completed but not published